Table 2.
Baseline Demographics and Clinical Characteristics of the Sample (N = 28)
| Characteristic | ||||
|---|---|---|---|---|
| Range | Mean (SD) | |||
| Age | 19–64 | 36.46 (13.57) | ||
| n | % | |
|---|---|---|
| Gender | ||
| Male | 8 | 28.6 |
| Female | 20 | 71.4 |
| Race/ethnicity | ||
| White | 18 | 64.3 |
| African American | 5 | 17.9 |
| American Indian or Alaskan Native | 1 | 3.6 |
| More than one selected | 3 | 10.7 |
| No response | 1 | 3.6 |
| Ethnicity | ||
| Hispanic/Latina | 11 | 39.3 |
| Non-Hispanic/Latina | 14 | 50.0 |
| No response | 3 | 10.7 |
| Education | ||
| Graduate | 7 | 25.0 |
| Part graduate/professional school | 3 | 10.7 |
| Undergraduate | 9 | 32.1 |
| Part undergraduate/2-year degree | 6 | 21.4 |
| High school | 2 | 7.1 |
| No response | 1 | 3.6 |
| Marital status | ||
| Never married | 14 | 50.0 |
| Married or living with someone | 6 | 21.4 |
| Separated or divorced | 3 | 10.7 |
| No response | 5 | 17.9 |
| Employment | ||
| Full time | 13 | 46.4 |
| Part time | 4 | 14.3 |
| Student | 5 | 17.9 |
| Not currently employed (e.g., laid off, leave of absence, homemaker, retired) | 6 | 21.4 |
| Current psychotropic medication use (i.e., ≥1 of the following: fluoxetine, bupropion, mirtazapine, lamotrigine, venlafaxine, citalopram, duloxetine) | 6 | 21.4 |
| Anxiety disorder diagnosis, per SCID criteria16 | ||
| One diagnosis | 7 | 25.0 |
| Two diagnoses | 2 | 7.1 |
| Generalized anxiety disorder | 4 | 14.3 |
| Panic disorder | 3 | 10.7 |
| Posttraumatic stress disorder | 1 | 3.6 |
| Social anxiety disorder | 1 | 3.6 |
| Specific phobia | 1 | 3.6 |
| Anxiety disorder, NOS | 1 | 3.6 |
NOS, not otherwise specified; SD, standard deviation; SCID, Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, 4th edition.